A Retrospective Trail Investigating Temozolomide Neoadjuvant Chemotherapy Combined with Radiotherapy in Low-Grade Pituitary Tumors

Table 2

Comparison of clinical efficacy [(%)].

Groups		Markedly effective	Effective	Ineffective	Total
Combined group	37	14	20	3	34 (91.89)
Control group	30	9	12	9	21 (70.00)
					5.4
					0.02